| 词条 | Normal pressure hydrocephalus | ||||||||||||||||||||
| 释义 |
| name = Normal-pressure hydrocephalus | synonyms = | image = | caption = | pronounce = | field = | symptoms = | complications = | onset = | duration = | types = | causes = | risks = | diagnosis = | differential = | prevention = | treatment = | medication = | prognosis = | frequency = | deaths = }}Normal-pressure hydrocephalus (NPH), also called communicating hydrocephalus and malresorptive hydrocephalus, is a condition in which excess cerebrospinal fluid (CSF) occurs in the ventricles, and with normal or slightly elevated cerebrospinal fluid pressure. As the fluid builds up, it causes the ventricles to enlarge and the pressure inside the head to increase, compressing surrounding brain tissue and leading to neurological complications. The disease presents in a classic triad of symptoms, which are urinary incontinence, dementia, and gait disturbance. The disease was first described by Hakim and Adams in 1965.[1] The treatment is surgical placement of a ventriculoperitoneal shunt to drain excess CSF into the lining of the abdomen where the CSF will eventually be absorbed. NPH is often misdiagnosed as Parkinson's disease (due to gait) or Alzheimer's disease (due to cognitive dysfunction). Signs and symptomsNPH exhibits a classic triad of clinical findings (known as the Adams triad or Hakim's triad). The triad consists of gait disturbance, dementia, and urinary incontinence (commonly referred to as "wet, wacky, and wobbly" or "weird walking water"). Gait disturbance is present in nearly all patients and usually the first symptom. This is caused by expansion of the lateral ventricles to impinge on the corticospinal tract motor fibers. The typical gait abnormality in NPH is a broad-based, slow, short-stepped, "stuck to the floor", or "magnetic" movement. The gait abnormalities in NPH may bear resemblance to a gait associated with Parkinson's disease. The gait disturbance can be classified as mild, marked, or severe. Marked is classified as difficulty walking because of considerable instability. Severe is classified as walking without aids (such as cane or wheeled walker) is not possible.[2][3]Dementia presents as progressive cognitive impairment which is present in 60% of patients at time of treatment. This is caused by distortions predominantly at the frontal lobe and the subcortex.[4] Initial deficits involve planning, organization, attention, and concentration. Further deficits include difficulty managing finances, taking medications, driving, keeping track of appoints, daytime sleeping, short-term memory impairments, and psychomotor slowing. Late stage features include apathy, reduced drive, slowed thinking, and reduced speech. Urinary incontinence appears late in the illness, and is present in 50% of patients at time of treatment. Urinary dysfunction begins as increased frequency often at night, and progresses to urge incontinence and permanent incontinence.[4]PathogenesisEvery day, the body makes roughly 600-700 ml of CSF, and about the same amount is reabsorbed into the bloodstream. Hydrocephalus is due to an imbalance between the amount of fluid produced and its absorption rate. Enlarged ventricles put increased pressure on the adjacent cortical tissue and cause myriad effects in the patient, including distortion of the fibers in the corona radiata. This leads to an increase in intracranial pressure (ICP). The ICP gradually falls, but still remains slightly elevated, and the CSF pressure reaches a high normal level of 150 to 200 mm H2O. Measurements of ICP, therefore, are not usually elevated. Because of this, patients do not exhibit the classic signs that accompany increased intracranial pressure such as headache, nausea, vomiting, or altered consciousness, although some studies have shown pressure elevations to occur intermittently. The exact pathogenesis is unknown, but consensus on some mechanisms include:
The syndrome is often divided into two groups, primary (also called idiopathic) and secondary, based on cause. The underlying etiology of primary NPH has not yet been identified. Primary NPH affects adults age 40 years or older, most commonly affecting the elderly. Secondary NPH can affect persons of any age and occurs due to conditions such as subarachnoid hemorrhage, meningitis, brain surgery, brain radiation, or traumatic brain injury. DiagnosisPatients with suspected NPH should have typical symptoms in addition to ventricular enlargement on neuroimaging. The international evidenced-based diagnostic criteria for primary NPH are:
MRI scans are preferred. The distinction between normal and enlarged ventricular size by cerebral atrophy is difficult to ascertain. Up to 80% of cases are unrecognized and untreated due to difficulty of diagnosis.[6] Imaging should also reveal the absence of any cerebral mass lesions or any signs of obstructions. Although all patients with NPH have enlarged ventricles, not all elderly patients with enlarged ventricles have primary NPH. Cerebral atrophy can cause enlarged ventricles, as well, and is referred to as hydrocephalus ex vacou. The Miller Fisher test involves a high-volume lumbar puncture (LP) with removal of 30-50 ml of CSF. Gait and cognitive function are typically tested just before and within 2-3 hours after the LP to assess for signs of symptomatic improvement. The CSF infusion test and the lumbar test are similar tests to Miller Fisher test. The tests have a positive predictive value over 90%, but a negative predictive value less than 50%. The LP should show normal or mildly elevated CSF pressure. CSF should have normal cell contents, glucose levels, and protein levels.[7][8][9] TreatmentVentriculoperitoneal shuntsFor suspected cases of NPH, CSF shunting is the first-line treatment. The most common type used to treat NPH is ventriculoperitoneal (VP) shunts, which drain CSF fluid to the peritoneal cavity. Adjustable valves allow fine-tuning of CSF drainage. NPH symptoms reportedly improve in 70-90% of patients with CSF shunt. Risk-benefit analyses have shown beyond any doubt that surgery for NPH is far better than conservative treatment or the natural course.[10] Gait symptoms improve in ≥ 85% patients. Cognitive symptoms improve in up to 80% of patients when surgery performed early in disease course. Incontinence improves in up to 80% of patients, but only in ≤ 50%-60% of patients with shunt implanted late in disease course. The most likely patients to show improvement are those who show only gait disturbance, mild or no incontinence, and mild dementia. The risk of adverse events related to shunt placement is 11%, including shunt failure, infections such as ventriculitis, shunt obstruction, over- or under-drainage, and development of a subdural hematoma.[11][12][13] MedicationsNo medications are effective for primary NPH. Acetazolamide and other diuretics are not recommended except for limited use in patients who are not candidates for placement of a shunt. EpidemiologyThe majority of cases are primary NPH. The incidence of NPH increases with advancing age, and most patients are over the age of 60. Its prevalence is reported to be less than 1% in persons under the age of 65, and up to 3% for persons aged 65 or older. No difference in incidence is seen between men and women.[14][15][16] Among individuals with dementia, the incidence of NPH is thought to be between 2 and 6%. See alsoLow pressure hydrocephalusReferences1. ^{{cite journal | vauthors = Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH | title = Symptomatic Occult Hydrocephalus with Normal Cerebrospinal-Fluid Pressure | journal = The New England Journal of Medicine | volume = 273 | issue = 3 | pages = 117–26 | date = July 1965 | pmid = 14303656 | doi = 10.1056/NEJM196507152730301 }} 2. ^{{cite book | vauthors = Krauss JK, Faist M, Schubert M, Borremans JJ, Lucking CH, Berger W | date = 2001 | chapter = Evaluation of Gait in Normal Pressure Hydrocephalus Before and After Shunting | veditors = Ruzicka E, Hallett M, Jankovic J | title = Gait Disorders | pages = 301–309 | location = Philadelphia, PA | publisher = Lippincott Williams & Wilkins }} 3. ^{{cite book | vauthors = Ropper AH, Samuels MA | date = 2009 | title = Adams and Victor’s Principles of Neurology | edition = 9th | location = New York, NY | publisher = McGraw-Hill Medical }} 4. ^{{cite journal|last1=Ishii|first1=Mitsuaki|last2=Kawamata|first2=Toshio|last3=Akiguchi|first3=Ichiro|last4=Yagi|first4=Hideo|last5=Watanabe|first5=Yuko|last6=Watanabe|first6=Toshiyuki|last7=Mashimo|first7=Hideaki|title=Parkinsonian Symptomatology May Correlate with CT Findings before and after Shunting in Idiopathic Normal Pressure Hydrocephalus|journal=Parkinson's Disease|volume=2010|year=2010|pages=1–7|issn=2042-0080|doi=10.4061/2010/201089}} 5. ^{{cite journal|last1=Damasceno|first1=Benito Pereira|title=Neuroimaging in normal pressure hydrocephalus|journal=Dementia & Neuropsychologia|volume=9|issue=4|year=2015|pages=350–355|issn=1980-5764|doi=10.1590/1980-57642015DN94000350}} 6. ^{{cite journal | vauthors = Kiefer M, Unterberg A | title = The differential diagnosis and treatment of normal-pressure hydrocephalus | journal = Deutsches Arzteblatt International | volume = 109 | issue = 1-2 | pages = 15–25; quiz 26 | date = January 2012 | pmid = 22282714 | pmc = 3265984 | doi = 10.3238/arztebl.2012.0015 }} 7. ^{{cite journal | vauthors = Tarnaris A, Toma AK, Kitchen ND, Watkins LD | title = Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus | journal = Biomarkers in Medicine | volume = 3 | issue = 6 | pages = 787–805 | date = December 2009 | pmid = 20477715 | doi = 10.2217/bmm.09.37 }} 8. ^{{cite journal | vauthors = Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM | title = The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus | journal = Neurosurgery | volume = 57 | issue = 3 Suppl | pages = S17-28; discussion ii-v | date = September 2005 | pmid = 16160426 | doi = 10.1227/01.neu.0000168184.01002.60 }} 9. ^{{cite web | work = National Institute of Neurological Disorders and Stroke | date = 29 April 2011 | title = NINDS Normal Pressure Hydrocephalus Information Page. | url = http://www.ninds.nih.gov/disorders/normal_pressure_hydrocephalus/normal_pressure_hydrocephalus.htm }} 10. ^{{cite journal | vauthors = Kiefer M, Unterberg A | title = The differential diagnosis and treatment of normal-pressure hydrocephalus | journal = Deutsches Arzteblatt International | volume = 109 | issue = 1-2 | pages = 15–25; quiz 26 | date = January 2012 | pmid = 22282714 | pmc = 3265984 | doi = 10.3238/arztebl.2012.0015 }} 11. ^{{cite journal | vauthors = Marmarou A, Young HF, Aygok GA | title = Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities | journal = Neurosurgical Focus | volume = 22 | issue = 4 | pages = E1 | date = April 2007 | pmid = 17613187 | doi = 10.3171/foc.2007.22.4.2 }} 12. ^{{cite journal | vauthors = Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD | title = Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review | journal = Neurology | volume = 42 | issue = 1 | pages = 54–9 | date = January 1992 | pmid = 1734324 | doi = 10.1212/wnl.42.1.54 }} 13. ^{{cite journal | vauthors = Poca MA, Mataró M, Del Mar Matarín M, Arikan F, Junqué C, Sahuquillo J | title = Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure | journal = Journal of Neurosurgery | volume = 100 | issue = 5 | pages = 855–66 | date = May 2004 | pmid = 15137605 | doi = 10.3171/jns.2004.100.5.0855 }} 14. ^1 2 {{cite book | vauthors = Younger DS | date = 2005 | chapter = Adult Normal Pressure Hydrocephalus | veditors = Younger DS | title = Motor Disorders | edition = 2nd | pages = 581–584 | location = Philadelphia, PA | publisher = Lippincott Williams & Wilkins }} 15. ^{{cite journal | vauthors = Brean A, Eide PK | title = Prevalence of probable idiopathic normal pressure hydrocephalus in a Norwegian population | journal = Acta Neurologica Scandinavica | volume = 118 | issue = 1 | pages = 48–53 | date = July 2008 | pmid = 18205881 | doi = 10.1111/j.1600-0404.2007.00982.x }} 16. ^{{cite journal | vauthors = Tanaka N, Yamaguchi S, Ishikawa H, Ishii H, Meguro K | title = Prevalence of possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri project | journal = Neuroepidemiology | volume = 32 | issue = 3 | pages = 171–5 | date = 1 January 2009 | pmid = 19096225 | doi = 10.1159/000186501 }} External links{{Medical resources| DiseasesDB = 9089 | ICD10 = {{ICD10|G|91|2|g|90}} | ICD9 = {{ICD9|331.9}}, {{ICD9|331.5}} | ICDO = | OMIM = | MedlinePlus = 000752 | eMedicineSubj = neuro | eMedicineTopic = 277 | eMedicine_mult = {{eMedicine2|radio|479}} | MeshID = D006850 }}{{Commons category|Normal pressure hydrocephalus}}
4 : Brain disorders|Geriatrics|Ventricular system|Medical triads |
||||||||||||||||||||
| 随便看 |
|
||||||||||||||||||||
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。